Cite
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.
MLA
Levin, Adeera, et al. “Executive Summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: Known Knowns and Known Unknowns.” Kidney International, vol. 105, no. 4, Apr. 2024, pp. 684–701. EBSCOhost, https://doi.org/10.1016/j.kint.2023.10.016.
APA
Levin, A., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., Lamb, E., Lin, P., Madero, M., McIntyre, N., Morrow, K., Roberts, G., Sabanayagam, D., Schaeffner, E., Shlipak, M., … Stevens, P. E. (2024). Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns. Kidney International, 105(4), 684–701. https://doi.org/10.1016/j.kint.2023.10.016
Chicago
Levin, Adeera, Sofia B Ahmed, Juan Jesus Carrero, Bethany Foster, Anna Francis, Rasheeda K Hall, Will G Herrington, et al. 2024. “Executive Summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: Known Knowns and Known Unknowns.” Kidney International 105 (4): 684–701. doi:10.1016/j.kint.2023.10.016.